Doyle Janeen Noel
SEC insider (Form 3/4/5 filer). CIK 0002069239. Chief Corp. & Bus. Dev. Ofcr at Janux Therapeutics, Inc. (JANX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 2, 2026. Located in SAN DIEGO, CA.
Companies Doyle Janeen Noel has filed insider reports for
- Janux Therapeutics, Inc. (JANX): Officer, Chief Corp. & Bus. Dev. Ofcr
Doyle Janeen Noel
CIK: 0002069239
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JANX
Janux Therapeutics, Inc.
Officer